本页面由Tiger Trade Technology Pte. Ltd.提供服务

GW Pharmaceuticals plc

218.96
0.0000
成交量:- -
成交额:- -
市值:69.07亿
市盈率:-98.44
高:218.96
开:218.96
低:218.96
收:218.96
52周最高:219.57
52周最低:87.07
股本:3,154.47万
流通股本:3,054.36万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.2244
每股收益(LYR):-1.8572
净资产收益率:-7.92%
总资产收益率:-3.55%
市净率:9.32
市盈率(LYR):-117.90

数据加载中...

2021/05/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/05/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/05/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/05/05

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/05/05

重要事件披露

8-K - Current report
2021/05/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/30

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/26

重要事件披露

8-K - Current report
2021/04/20

重要事件披露

8-K - Current report
2021/04/14

重要事件披露

8-K - Current report
2021/03/23

重要事件披露

8-K - Current report
2021/03/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/26

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

重要事件披露

8-K - Current report
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/03

重要事件披露

8-K - Current report
2021/02/03

重要事件披露

8-K - Current report
2021/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals